• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Sectors Health

Tinubu applauds NAFDAC for retaining WHO Maturity Level 3 status in medicines, vaccines regulation 

Anthonia Obokoh by Anthonia Obokoh
August 11, 2025
in Health, Sectors
Tinubu applauds NAFDAC for retaining WHO Maturity Level 3 status in medicines, vaccines regulation 
Share on FacebookShare on TwitterShare on Linkedin

President Bola Tinubu has congratulated the National Agency for Food and Drug Administration and Control (NAFDAC) on retaining the World Health Organization’s (WHO) Maturity Level 3 (ML3) status for the regulation of medicines and vaccines.

According to a statement by Presidential spokesman Bayo Onanuga, shared on X on Monday, the global health regulatory body conducted a re-benchmarking exercise from May 28 to May 30, 2025, assessing NAFDAC against globally recognized standards for regulatory performance.

NAFDAC attained ML3 status in 2022, becoming Africa’s first National Regulatory Authority to achieve this milestone in regulating medicines and vaccines (non-producing). In consonance with the WHO policy, periodic reviews are conducted to ensure sustained compliance.

MoreStories

NESG

NESG warns of growing deindustrialisation as Nigeria’s manufacturing sector remains weak 

March 8, 2026

Benson Ndeta: Kenyan court issues arrest warrant over alleged $35M fraud 

March 8, 2026

Evaluation process and institutional development plan 

The latest evaluation followed a formal re-benchmarking in November 2024 and five Institutional Development Plan (IDP) review meetings between February and April 2025 to assess progress on corrective actions.

President Tinubu welcomes the WHO’s verdict that:

“NAFDAC has successfully maintained a regulatory system that operates as a stable, well-functioning, and integrated framework for regulating medicines and vaccines (non-producing).  

“This achievement results from investment by the Government of Nigeria in strengthening the regulatory system,” he said. 

Recognition of NAFDAC’s staff and commitment to public health 

The President commends NAFDAC’s management and staff for their professionalism, consistency, and dedication to safeguarding public health, noting that this achievement strengthens Nigeria’s standing as a reliable partner in global health security and pandemic preparedness.

President Tinubu reaffirms his administration’s unwavering commitment to enhancing Nigeria’s capacity to ensure the safety, quality, and efficacy of medicines and vaccines in line with international best practices.

He emphasizes that this milestone complements his administration’s Renewed Hope Agenda to transform Nigeria’s healthcare system.

Ongoing healthcare infrastructure and training initiatives 

The President acknowledges the progress in the administration’s initiatives to upgrade over 17,000 primary health centres nationwide, improve maternal care and diagnostics in underserved communities, train 120,000 frontline health workers, and double national health insurance coverage within three years.

He underscores that promoting local production of healthcare products remains a priority.

President Tinubu pledges that Nigeria will continue collaborating with credible partners, development agencies, and donor organizations to promote the pharmaceutical sector, attract investment in health-related industries, and expand local manufacturing capacity.

He assures that his administration will continue to support NAFDAC in its journey towards achieving WHO’s Maturity Level 4, the highest global standard of regulatory excellence.

Tags: NAFDACPresident Bola Tinubuvaccines regulationWHO Maturity Level 3
Anthonia Obokoh

Anthonia Obokoh

Anthonia Obokoh is journalist with years experience in the media industry, focusing on health reporting. Known for her expertise as a health writer and analyst, she brings depth to topics from public health policies to healthcare advancements. Her work has earned her recognition as a trusted voice in Nigeria’s health journalism field.

Next Post
Hutu Exclusive by Mshel Homes: Abuja’s premier investment opportunity redefining luxury living 

Hutu Exclusive by Mshel Homes: Abuja’s premier investment opportunity redefining luxury living 

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast
rabafast

nairametrics





DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics